Delivery Order SPE2DB22D3401-SPE2DB24FT2HF
Award Date
3/20/24
Potential Completion Date
3/21/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Insulin Glargine-yfgn U100 Pen 3ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $3,954.24. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 13, 2024. This award is not...
This federal contract award is for the delivery of insulin glargine-yfgn U100 pens to the Defense Logistics Agency (DLA). The $23,921.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 3, 2024, with a completion date of September 4, 2024. The contract is not set aside for any particular business type. This order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for insulin glargine-yfgn U100 pens, with a ceiling value of $29,447.88 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no small business...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of insulin glargine-yfgn U100 pens with a total ceiling value of $2,471.40 and a period of performance through March 27, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,091.04 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens. The contract has an ultimate completion date of November 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide insulin glargine-yfgn U100 pens. The contract has a ceiling value of $1,872.71 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,582.59 firm fixed-price delivery order is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a type of insulin medication. The contract has an ultimate completion date of January 21, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order with a ceiling value of $1,459.57 under the Defense Logistics Agency (DLA) Troop Support Medical contract. The contract is for the firm fixed price delivery of insulin glargine-yfgn U100 pens. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564029748 - Insulin Glargine-YFGN U100 Pen 3 ML. The contract, valued at $6,590.40, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,244.19 Firm Fixed Price Delivery Order covers the supply of Insulin Glargine-yfgn U100 Pens with an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...